+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Iodine-131 Isotope Market by Application, End User, Form, Therapeutic Procedures, Patient Demographics - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6016558
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Iodine-131 Isotope Market grew from USD 5.20 billion in 2023 to USD 5.52 billion in 2024. It is expected to continue growing at a CAGR of 6.48%, reaching USD 8.07 billion by 2030.

The market for Iodine-131, a radioactive isotope used primarily in medical applications, exhibits a robust scope driven by its critical role in diagnostics and treatment within nuclear medicine. Primarily, Iodine-131 is utilized in radiotherapy for thyroid disorders, including hyperthyroidism and thyroid cancer, due to its ability to selectively target and destroy thyroid cells. Its application extends to diagnostic tests such as thyroid uptake tests, contributing to its necessity in healthcare. The end-use sectors predominantly include hospitals, cancer treatment centers, and diagnostic laboratories, emphasizing the isotope's medical relevance. The market's growth is influenced by the increasing global prevalence of thyroid diseases and the expanding aging population that demands efficient diagnostic tools. Technological advancements in radioisotope production and the growing healthcare infrastructure in emerging economies present lucrative opportunities for market expansion. Stakeholders can capitalize on these by investing in advanced production facilities and forming strategic partnerships with healthcare providers.

However, the market faces limitations due to stringent regulatory requirements and potential safety hazards associated with radioactive materials. Additionally, the high cost of production and handling challenges pose significant barriers. Compounding these challenges is the competition from alternative treatments such as surgery and other isotopes, which may impede market growth.

Innovation in this field could revolve around improving the efficiency of Iodine-131 production methods and enhancing the safety measures in its handling and application. Research could focus on developing novel formulations or combination therapies that maximize its therapeutic effects while minimizing side effects. The market is characterized by its fragmented nature, with several players competing through technological advancements and strategic partnerships. The dominance of well-established healthcare systems in developed regions is complemented by growing opportunities in untapped markets where healthcare modernization is underway. Focusing on improving accessibility and cost-effectiveness of treatment options can serve as a significant growth lever in this market.

Understanding Market Dynamics in the Iodine-131 Isotope Market

The Iodine-131 Isotope Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
    • Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
    • Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
  • Market Restraints
    • Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
  • Market Opportunities
    • Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
    • Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
    • Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
  • Market Challenges
    • Competition from alternative diagnostic and therapeutic isotopes

Exploring Porter’s Five Forces for the Iodine-131 Isotope Market

Porter’s Five Forces framework further strengthens the insights of the Iodine-131 Isotope Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Iodine-131 Isotope Market

External macro-environmental factors deeply influence the performance of the Iodine-131 Isotope Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Iodine-131 Isotope Market

The Iodine-131 Isotope Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Iodine-131 Isotope Market

The Iodine-131 Isotope Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Iodine-131 Isotope Market

The Iodine-131 Isotope Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Iodine-131 Isotope Market, highlighting leading vendors and their innovative profiles. These include Advanced Accelerator Applications, Bayer AG, BRAHMS GmbH, Canon Medical Systems, Cardinal Health, Cardinal Health Nuclear & Precision Health Solutions, Curium, Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Isotopia Molecular Imaging, Mallinckrodt Pharmaceuticals, Medtronic, Nordion, NorthStar Medical Radioisotopes, NTP Radioisotopes, Philips Healthcare, Siemens Healthineers, Smiths Medical, and ZymoGenetics.

Market Segmentation & Coverage

This research report categorizes the Iodine-131 Isotope Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Application
    • Agricultural
      • Pest Control
      • Soil Fertility Research
    • Industrial
      • Diagnostics
      • Radiation Therapy
    • Medical
      • Hyperthyroidism Treatment
      • Research and Development
      • Thyroid Cancer Treatment
    • Pharmaceutical
      • Radiopharmaceuticals
  • End User
    • Agricultural Sector
    • Hospitals and Clinics
      • Private Hospitals
      • Public Hospitals
    • Pharmaceutical Companies
    • Research Institutes
      • Academic Research Institutes
      • Medical Research Institutes
  • Form
    • Capsules
    • Gas
    • Liquid
  • Therapeutic Procedures
    • Radioactive Iodine Ablation
    • Radioactive Iodine Therapy
    • Whole-Body Scan
  • Patient Demographics
    • Adults
    • Pediatrics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
5.1.1.2. Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
5.1.1.3. Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
5.1.2. Restraints
5.1.2.1. Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
5.1.3. Opportunities
5.1.3.1. Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
5.1.3.2. Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
5.1.3.3. Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
5.1.4. Challenges
5.1.4.1. Competition from alternative diagnostic and therapeutic isotopes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Iodine-131 Isotope Market, by Application
6.1. Introduction
6.2. Agricultural
6.2.1. Pest Control
6.2.2. Soil Fertility Research
6.3. Industrial
6.3.1. Diagnostics
6.3.2. Radiation Therapy
6.4. Medical
6.4.1. Hyperthyroidism Treatment
6.4.2. Research and Development
6.4.3. Thyroid Cancer Treatment
6.5. Pharmaceutical
6.5.1. Radiopharmaceuticals

7. Iodine-131 Isotope Market, by End User
7.1. Introduction
7.2. Agricultural Sector
7.3. Hospitals and Clinics
7.3.1. Private Hospitals
7.3.2. Public Hospitals
7.4. Pharmaceutical Companies
7.5. Research Institutes
7.5.1. Academic Research Institutes
7.5.2. Medical Research Institutes

8. Iodine-131 Isotope Market, by Form
8.1. Introduction
8.2. Capsules
8.3. Gas
8.4. Liquid

9. Iodine-131 Isotope Market, by Therapeutic Procedures
9.1. Introduction
9.2. Radioactive Iodine Ablation
9.3. Radioactive Iodine Therapy
9.4. Whole-Body Scan

10. Iodine-131 Isotope Market, by Patient Demographics
10.1. Introduction
10.2. Adults
10.3. Pediatrics

11. Americas Iodine-131 Isotope Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Iodine-131 Isotope Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Iodine-131 Isotope Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation


List of Figures
FIGURE 1. IODINE-131 ISOTOPE MARKET RESEARCH PROCESS
FIGURE 2. IODINE-131 ISOTOPE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2030 (%)
FIGURE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2030 (%)
FIGURE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. IODINE-131 ISOTOPE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. IODINE-131 ISOTOPE MARKET, FPNV POSITIONING MATRIX, 2023


List of Tables
TABLE 1. IODINE-131 ISOTOPE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. IODINE-131 ISOTOPE MARKET DYNAMICS
TABLE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEST CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY SOIL FERTILITY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HYPERTHYROIDISM TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THYROID CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL SECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY WHOLE-BODY SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 80. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 82. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 83. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 84. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 85. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 87. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 88. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 90. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 91. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 93. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 94. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 95. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 96. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 99. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 100. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 101. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 114. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 116. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 118. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 121. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 122. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 126. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 128. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 129. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 130. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 131. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 133. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 134. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 137. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 139. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 140. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 141. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 142. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 144. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 145. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 147. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 148. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 150. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 151. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 152. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 153. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 155. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 156. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 157. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 158. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 159. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 161. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 162. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 163. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 164. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 166. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 167. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 170. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 172. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 173. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 174. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 175. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 177. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 178. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 179. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 180. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 181. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 183. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 184. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 185. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 186. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 188. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 189. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 192. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 194. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 195. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 196. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 197. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 199. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 200. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 203. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 205. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 206. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 207. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 208. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 210. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 211. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 214. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 216. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 217. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 218. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 219. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 221. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 222. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 225. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 227. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 228. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 236. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 238. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 239. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 240. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 241. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 243. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 244. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 245. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 246. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 247. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 249. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 250. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 251. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 252. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 254. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 255. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 272. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 273. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 274. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 275. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 277. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 278. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 279. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 280. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 281. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 283. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 284. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 285. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 286. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 288. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 289. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 290. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 291. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 292. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 294. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 295. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 296. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 297. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 299. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 300. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 301. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 302. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 303. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 305. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 306. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 307. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 308. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 309. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 310. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 311. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 312. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 313. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 314. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 316. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 317. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 318. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 319. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 321. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 322. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 323. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 324. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 333. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 334. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 335. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 336. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 337. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 338. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 339. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 340. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 341. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 342. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 343. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 344. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 345. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
TABLE 346. ITALY IODINE-131 ISOTOP

Companies Mentioned

The leading players in the Iodine-131 Isotope Market, which are profiled in this report, include:
  • Advanced Accelerator Applications
  • Bayer AG
  • BRAHMS GmbH
  • Canon Medical Systems
  • Cardinal Health
  • Cardinal Health Nuclear & Precision Health Solutions
  • Curium
  • Eckert & Ziegler
  • GE Healthcare
  • IBA Radiopharma Solutions
  • Isotopia Molecular Imaging
  • Mallinckrodt Pharmaceuticals
  • Medtronic
  • Nordion
  • NorthStar Medical Radioisotopes
  • NTP Radioisotopes
  • Philips Healthcare
  • Siemens Healthineers
  • Smiths Medical
  • ZymoGenetics

Methodology

Loading
LOADING...

Table Information